Duration of cooling with water for thermal burns as a first aid intervention: A systematic review.


Journal

Burns : journal of the International Society for Burn Injuries
ISSN: 1879-1409
Titre abrégé: Burns
Pays: Netherlands
ID NLM: 8913178

Informations de publication

Date de publication:
03 2022
Historique:
received: 04 03 2021
revised: 13 09 2021
accepted: 18 10 2021
pubmed: 18 12 2021
medline: 13 4 2022
entrez: 17 12 2021
Statut: ppublish

Résumé

Cooling thermal burns with running water is a recommended first aid intervention. However, guidance on the ideal duration of cooling remains controversial and inconsistent across organisations. To perform a systematic review of the evidence for the question; Among adults and children with thermal burn, does active cooling using running water as an immediate first aid intervention for 20 min or more, compared with active cooling using running water for any other duration, change the outcomes of burn size, burn depth, pain, adverse outcome (hypothermia) or complications? We searched Medline, Embase, Cochrane Database of Systematic Reviews and used ROBINS-I to assess for risk of bias. We used Grading of Recommendations, Assessment, Development and Evaluation methodology for determining the certainty of evidence. We included all studies that compared the selected outcomes of the duration of cooling of thermal burns with water in all patient ages. (PROSPERO registration number: CRD42021180665). From 560 screened references, we included four observational studies. In these studies, 48% of burns were cooled for 20 min or more. We found no benefit for a duration of 20 min or more of cooling when compared with less than 20 min of cooling for the outcomes of size and depth of burn, re-epithelialization, or skin grafting. The evidence is of very low certainty owing to limitations in study design, risk of bias and indirectness. The optimal duration of cooling for thermal burns remains unknown and future prospective research is indicated to better define this treatment recommendation.

Sections du résumé

BACKGROUND
Cooling thermal burns with running water is a recommended first aid intervention. However, guidance on the ideal duration of cooling remains controversial and inconsistent across organisations.
AIM
To perform a systematic review of the evidence for the question; Among adults and children with thermal burn, does active cooling using running water as an immediate first aid intervention for 20 min or more, compared with active cooling using running water for any other duration, change the outcomes of burn size, burn depth, pain, adverse outcome (hypothermia) or complications?
METHOD
We searched Medline, Embase, Cochrane Database of Systematic Reviews and used ROBINS-I to assess for risk of bias. We used Grading of Recommendations, Assessment, Development and Evaluation methodology for determining the certainty of evidence. We included all studies that compared the selected outcomes of the duration of cooling of thermal burns with water in all patient ages. (PROSPERO registration number: CRD42021180665). From 560 screened references, we included four observational studies. In these studies, 48% of burns were cooled for 20 min or more. We found no benefit for a duration of 20 min or more of cooling when compared with less than 20 min of cooling for the outcomes of size and depth of burn, re-epithelialization, or skin grafting. The evidence is of very low certainty owing to limitations in study design, risk of bias and indirectness.
CONCLUSION
The optimal duration of cooling for thermal burns remains unknown and future prospective research is indicated to better define this treatment recommendation.

Identifiants

pubmed: 34916091
pii: S0305-4179(21)00294-1
doi: 10.1016/j.burns.2021.10.007
pii:
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-262

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors and members of the Task Force collaborating or acknowledged have no conflicts of interest relevant to this article to disclose.

Auteurs

Therese Djärv (T)

Department of Medicine Solna, Karolinska Institute and Division of Acute and Reparative Medicine, Karolinska University Hospital, Sweden. Electronic address: therese.djarv@ki.se.

Matthew Douma (M)

Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Canada. Electronic address: matthewjdouma@gmail.com.

Tina Palmieri (T)

Burn Division, University of California Davis and Shriners Hospital for Children Northern California, Sacramento, CA, USA. Electronic address: tlpalmieri@ucdavis.edu.

Daniel Meyran (D)

Bataillon de Marins Pompiers de Marseille, French Red Cross, France. Electronic address: daniel.meyran@croix-rouge.fr.

David Berry (D)

Department of Kinesiology, Saginaw Valley State University, University Center, MI, USA. Electronic address: dcberry@svsu.edu.

David Kloeck (D)

Department of Critical Care, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: David.Kloeck@wits.ac.za.

Jason Bendall (J)

Department of Rural Health, University of Newcastle, Newcastle, Australia. Electronic address: Jason.bendall@newcastle.edu.au.

Laurie J Morrison (LJ)

Emergency Department, St Michael´s Hospital, Division of Emergency Medicine, Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: Laurie.Morrison@unityhealth.to.

Eunice M Singletary (EM)

University of Virginia, Department of Emergency Medicine, Charlottesville, VA, USA. Electronic address: niciems1@gmail.com.

David Zideman (D)

Thames Valley Air Ambulance, Oxford, UK. Electronic address: david.zideman@tvairambulance.org.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH